Clinical Trial Update: A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 2 clinical trial evaluating E2814 in combination with lecanemab in people with early Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• E2814
• LEQEMBI (lecanemab)

Snippet

Sponsor: Eisai Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING